Effects of Cyclic GMP on Smooth Muscle Relaxation

Advances in Pharmacology

Volumn 26, Issue C, 1994, Pages 171-194

  Warner, Timothy D ^a   Mitchell, Jane A ^a   Sheng, Hong ^b   Murad, Ferid ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Molecular Geriatrics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; ISOENZYME;

ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MUSCLE RELAXATION; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE;

ANIMALS; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; ISOENZYMES; MUSCLE RELAXATION; MUSCLE, SMOOTH;

EID: 0028250339     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60054-X     Document Type: Article

References (177)

1. Ahlner, J., Torfgård, R., Andersson, G.G., Axelsson, K., Organic nitrate esters: Clinical use and mechanisms of actions. Pharmacol. Rev. 43 (1991), 351–423.
2. Ahlner, J., Ljusegren, M.E., Grundström, N., Axelsson, K.L., Role of nitric oxide and cyclic GMP as mediators of endothelium-independent neurogenic relaxation in bovine mesenteric artery. Circ. Res. 68 (1991), 756–762.
3. Arnold, W.P., Mittal, C, Katsuki, S., Murad, F., Nitric oxide activates guanylate cyclase and increase guanosine 3′: 5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U.S.A. 74 (1977), 3203–3207.
4. Baird, A.A., Muir, T.C., Membrane hyperpolarization, cyclic nucleotide levels and relaxation in the guinea-pig internal anal sphincter. Br. J. Pharmacol. 100 (1990), 329–335.
5. Baltensperger, K., Chiesi, M., Carafoli, E., Substrates of cGMP kinase in vascular smooth muscle and their role in the relaxation process. Biochemistry 29 (1990), 9753–9760.
6. Beasley, D., Interleukin and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am. J. Physiol. 259 (1990), R38–R-44.
7. Beasley, D., Cohen, R.A., Levinsky, N.G., Interleukin-1 inhibits contraction of vascular smooth muscle. J. Clin. Invest. 83 (1989), 331–335.
8. Beasley, D., Cohen, R.A., Levinsky, N.G., Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am. J. Physiol. 258 (1989), HI187–HI192.
9. Beasley, D., Schwartz, J.H., Brenner, B.M., Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87 (1991), 602–608.
10. Bennett, B., Leitman, D., Schroder, H., Kauramotto, J., Nakatsu, K., Murad, F., Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultural cell lines. J. Pharmacol. Exp. Ther. 250 (1989), 316–323.
11. Bernhardt, J., Tschudi, M.R., Dohi, Y., Gut, I., Urwyler, B., Bühler, F.R., Lüscher, T.F., Release of nitric oxide from human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 180 (1991), 907–912.
12. Boeckxtaens, G.E., Pelckmans, P.A., Borgers, J.J., Bult, H., De Man, J.G., Osterboch, L., Herman, A.G., Van Maercke, Y.M., Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in rat gastric fundus. J. Pharmacol. Exp. Ther. 256 (1991), 441–447.
13. Bowman, A., Drummond, A.H., Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle. Br. J. Pharmacol. 81 (1984), 665–674.
14. Bowman, A., McGrath, J.C., The effect of hypoxiaon neuroeffector transmission in the bovine retractor penis and rat anococcygeus muscles. Br. J. Pharmacol. 85 (1985), 869–875.
15. Bowman, A., Gillespie, J.S., Pollock, P., Oxyhaemoglobin blocks non-adrenergic non-cholindergic inhibition in the bovine retractor penis muscle. Eur. J. Pharmacol. 85 (1982), 221–224.
16. Budzik, G.P., Firestone, S.L., Bush, E.N., Connolly, P.J., Rockway, T.W., Sarin, V.K., Holleman, W., Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: Evidence for receptor subtypes. Biochem. Biophys. Res. Commun. 144 (1987), 422–431.
17. Buechler, W.A., Nakane, M., Murad, F., Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem. Biophys. Res. Commun. 174 (1991), 351–357.
18. Bult, H., Boeckxstaens, G.E., Pelckmans, P.A., Jordaens, F.H., Van Maercke, Y.M., Herman, A.G., Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature (London) 345 (1990), 346–347.
19. Busse, R., Mülsch, A., Induction of nitric oxide synthase by cytokines on vascular smooth muscle cells. FEBS Lett. 275 (1990), 87–90.
20. Caroni, P., Carafoli, E., The regulation of the Na+ -Ca2+ exchanger of the heart sarcolemma. Eur. J. Biochem. 132 (1983), 451–460.
21. Chang, M.S., Lowe, D.C., Lewis, M., Hellmiss, R., Chen, E., Goeddel, D.V., Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature (London) 341 (1989), 68–72.
22. Chinkers, M., Garbers, D.L., Chang, M.-S., Lowe, D.G., Chin, H., Goeddel, D.V., Schulz, S., A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (London) 338 (1989), 78–83.
23. Chuprun, J.K., Rapoport, R.M., Nitroglycerine-induced desensitization of vascular smooth muscle may be mediated through cyclic GMP-disinhibition of phosphati-dylinositol hydrolysis. Experientia 43 (1987), 316–318.
24. Cohen, R.A., Weisbrodt, R.M., The endothelium inhibits release of norepinephrine from rabbit carotid artery during electrical stimulation. Am. J. Physiol., 255, 1988, H871.
25. Cook, N.J., Hanke, W., Kaupp, U.B., Identification, purification and functional reconstitution of the cyclic GMP-dependent channel from rod photoreceptors. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 585–589.
26. Corbin, J.D., Ogreid, D., Miller, J.P., Suva, R.H., Jastorff, B., Doskeland, S.O., Studies of cGMP analog specificity and function of two intrasubunit binding sites of cGMP-dependent protein kinase. J. Biol Chem. 261 (1986), 1208–1214.
27. Cornwell, T.L., Lincoln, T.M., Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells: Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J. Biol. Chem. 264 (1989), 1146–1155.
28. Currie, M.G., Geller, D.M., Cole, B., Boylan, J.G., Shenz, W.Y., Holmberg, S.W., Needleman, P., Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria. Science 221 (1983), 71–73.
29. de Bold, A.J., Borenstein, H.B., Veress, A.T., Sonnenberg, H., A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981), 89–94.
30. Desai, K.M., Sessa, W.C., Vane, J.R., Involvement of nitric oxide in the reflex relaxation of the stomach to accomodate food and fluid. Nature (London) 351 (1991), 477–479.
31. Desai, K.M., Zemobowicz, A., Sessa, W.C., Vane, J.R., Nitroxergic nerves mediate vagally induced relaxation in the isolated stomach of the guinea pig. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 11490–11494.
32. DiPolo, R., Beaugé, L., In squid axons, ATP modulates Na+ -CA2+ exchange by a Ca2+ i-dependent phosphorylation. Biochim. Biophys. Acta 897 (1987), 347–354.
33. Dokita, S., Morgan, W.R., Wheeler, M.A., Yoshida, M., Latifpour, J., Weiss, R.M., NG-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscle. Life Sci. 48 (1991), 2429–2436.
34. Drewett, J.G., Trachte, G.J., Marchand, G.R., Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens. J. Pharmacol. Exp. Ther. 248 (1989), 135–142.
35. Drewett, J.G., Ziegler, R.J., Trachte, G.J., Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochro-mocytoma cells. J. Pharmacol. Exp. Ther. 255 (1990), 497–503.
36. Faison, E.P., Siegl, P.K.S., Moran, G., Winquist, R.J., Regional vasorelaxant selectivity of atrial natriuretic factor in isolated rabbit vessels. Life Sci. 37 (1985), 1073–1079.
37. Feelisch, M., Noack, E., Schroder, H., Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation. Eur. Heart J. 9:Suppl. A (1988), 57–62.
38. Fink, M.P., Homer, L.D., Fletcher, J.R., Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin mediated effect. J. Surg. Res. 38 (1985), 335–342.
39. Fiscus, R.R., Rapoport, R.M., Waldman, S.A., Murad, F., Atriopeptin II elevates cyclic GMP, activates cyclic GMP-dependent protein kinase, and causes relaxation in rat thoracic aorta. Biochim. Biophys. Acta 846 (1985), 179–184.
40. Fleming, I., Gray, G.A., Julou-Schaeffer, G., Parratt, J.R., Stoclet, J.-C., Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171 (1990), 562–568.
41. Flockerzi, V., Speichermann, N., Hofmann, F., A guanosine 3′ :5′-mono-phosphate protein kinase from bovine heart muscle: Purification and phosphorylation of histone I and IIb. J. Biol. Chem. 253 (1978), 3395–3399.
42. Flynn, T.G., Brar, A., Tremblay, L., Sarda, I., Lyons, C., Jennings, D.B., Isolation and characterization of ISO-rANP, a new natriuretic peptide. Biochem. Biophys. Res. Commun. 161 (1989), 830–837.
43. Förstermann, U., Mülsch, A., Böhme, E., Büsse, R., Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-dependent factor from rabbit and canine arteries. Circ. Res. 58 (1986), 531–538.
44. Fujii, K., Ishimatsu, T., Kuriyama, H., Mechanism of vasodilation induced by α-human atrial natriuretic polypeptide in rabbit and guinea pig renal arteries. J. Physiol. (London) 377 (1986), 315–332.
45. Furchgott, R.F., Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is organic nitrite and the endothelium-derived relaxing factor is nitric oxide. Vanhoutte, P.M., (eds.) “Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium”, 1988, Raven Press, New York, 401–414.
46. Furchgott, R.F., Zawadzki, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature (London) 288 (1980), 373–376.
47. Furchgott, R.F., Cherry, P.D., Zawadzki, J.V., Jothianandan, D., Endothelial cells as mediators of vasodilation of arteries. J. Cardiovasc. Pharmacol. 6 (1984), S336–S343.
48. Furukawa, K.-I., Tawada, Y., Shigekawa, M., Regulation of the plasma membrane Ca2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J. Biol. Chem. 263 (1988), 8058–8065.
49. Furukawa, K.-I., Ohshima, N., Tawada-Iwata, Y., Shigekawa, M., Cyclic GMP stimulates Na+ /Ca2+ exchange in vascular smooth muscle cells in primary culture. J. Biol. Chem. 266 (1991), 12337–12341.
50. Garbers, D.L., Sea urchin sperm guanylate cyclase: Purification and loss of cooperativity. J. Biol. Chem. 251 (1976), 4071–4077.
51. Gharaibeh, M.N., Gross, G.J., Comparative relaxant effects of nitroglycerin in isolated rings from various canine vascular beds. Gen. Pharmacol. 15 (1984), 217–221.
52. Gibson, A., Mirzazadeh, S., Hobbs, A.J., Moore, P.K., L-NG-Monomethyl-arginine and L-NG-nitro-arginine inhibit non-adrenergic non-cholinergic relaxation of the mouse anococcygeus muscle. Br. J. Pharmacol. 99 (1990), 602–606.
53. Gill, G.N., Holdy, K.E., Walton, G.M., Kanstein, C.B., Purification and characterization of 3′ :5′-cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 73 (1976), 3918–3922.
54. Gillespie, J.S., The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol. 45 (1972), 404–416.
55. Gillespie, J.S., Liu, X., Martin, W., The effect of L-arginine and NG-monomethyl-L-arginine on the response of the rat anococcygeus muscle to NANC stimulation. Br. J. Pharmacol. 98 (1989), 1080–1082.
56. Glauser, M.P., Zanetti, G., Baumgartner, J.-D., Cohen, J., Septic shock: Pathogenesis. Lancet 338 (1991), 732–736.
57. Greenberg, S.S., Diecke, F.P.J., Cantor, E., Peevy, K., Tanaka, T.P., Inhibition of sympathetic neurotransmitter release by modulators of cyclic GMP in canine vascular smooth muscle. Eur. J. Pharmacol. 187 (1990), 409–423.
58. Greenberg, S.S., Cantor, E., Diecke, F.P.J., Tanaka, T.P., Cyclic GMP modulates release of norepinephrine from adrenergic nerves innervating canine arteries. Am. J. Hypertens. 4 (1991), 173–176.
59. Gruetter, C.A., Barry, B.K., McNamara, D.B., Gruetter, D.Y., Kadowitz, P.J., Ignarro, L.J., Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J. Cyclic Nucleotide Res. 5 (1979), 211–224.
60. Gruetter, C.A., Gruetter, D.Y., Lyon, E.J., Kadowitz, P.J., Ignarro, L.J., Relation between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary artery smooth muscle by gylceryltrinitrate, nitroprusside, nitrite, and nitric oxide: Effects of methylene blue and methemoglobin. J. Pharmacol. Exp. Ther. 219 (1981), 181–186.
61. Gruetter, C.A., Kadowitz, P.J., Ignarro, L.J., Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amylnitrate. Can. J. Physiol. Pharmacol. 59 (1981), 150–165.
62. Harder, D.R., Belardinelli, L., Sprelakis, N., Rubio, R., Berne, R.M., Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ. Res. 44 (1979), 176–182.
63. Harteneck, C., Koesling, D., Söling, A., Schultz, G., Böhme, E., Expression of soluble guanylate cyclase. Catalytic activity requires two enzyme subunits. FEBS Lett. 272 (1990), 221–223.
64. Hibbs, J.R. Jr., Taintor, R.R., Vavrin, Z., Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235 (1987), 473–476.
65. Hirata, M., Kohse, K.P., Chang, C.-H., Ikebe, T., Murad, F., Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem. 265 (1990), 1268–1273.
66. Ignarro, L.J., Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: A unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67 (1990), 1–7.
67. Ignarro, L.J., Edwards, J.C., Gruetter, D.Y., Barry, B.K., Gruetter, C.A., Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett. 110 (1980), 275–278.
68. Ignarro, L.J., Lippton, H., Edwards, J.C., Baricos, W.H., Hyman, A.L., Kadowitz, P.J., Gruetter, C.A., Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitirc oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218 (1981), 739–749.
69. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., Chaudhuri, G., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 9265–9269.
70. Ignarro, L.J., Bush, P.A., Buga, G.M., Wood, K.S., Fukuto, J.M., Rajfer, J., Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 170 (1990), 843–850.
71. Ignarro, L.J., Bush, P.A., Buga, G.M., Rajfer, J., Neurotransmitter identity doubt. Nature (London) 347 (1990), 131–132.
72. Imai, S., Yoshida, Y., Sun, H.-T., Sarcolemmal (Ca2+ + Mg2+)-ATPase of vascular smooth muscle and the effects of protein kinases thereupon. J. Biochem. (Tokyo) 107 (1990), 755–761.
73. Ives, H.E., Casnellie, J.E., Greengard, P., Jamieson, J.D., Subcellular localization of cyclic GMP-dependent protein kinase and its substrates in vascular smooth muscle. J. Biol. Chem. 255 (1980), 3777–3785.
74. Jackson, W.F., Mülsch, A., Busse, R., Rhythmic smooth muscle activity in hamster aortas is mediated by continuous release of NO from endothelium. Am. J. Physiol. 260 (1991), H248–H253.
75. Julou-Schaeffer, G., Gray, G.A., Fleming, I., Schott, C., Parratt, J.R., Stoclet, J.-C., Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259 (1990), H1038–H1043.
76. Kambayashi, Y., Nakao, K., Itoh, H., Hosoda, K., Saito, Y., et al. Isolation and sequence determination of rat cardiac natriuretic peptide. Biochem. Biophys. Res. Com-mun. 63 (1989), 233–240.
77. Kamisaki, Y., Saheki, S., Nakane, M., Palmieri, J.A., Kuno, T., Chang, B.Y., Waldman, S.A., Murad, F., Soluble guanylate cyclase from rat lung exists as a hetero-ditner. J. Biol. Chem. 261 (1986), 7236–7241.
78. Katsuki, S., Murad, F., Regulation of adenosine cyclic 3′: 5′-monophosphate and guanosine 3′ :5′-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol. Pharmacol. 13 (1977), 330–341.
79. Katsuki, S., Arnold, W., Mittal, C., Murad, F., Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3 (1977), 23–35.
80. Katsuki, S., Arnold, W.P., Murad, F., Effect of sodium nitroprusside, nitroglycerin and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J. Cyclic Nucleotide Res. 3 (1977), 239–247.
81. Kauffman, R.F., Schenck, K.W., Utterback, G., Crowe, V.G., Cohen, M.L., In vitro vascular relaxation by new inotropic agents: Relationship to phosphodiesterase inhibition and cyclic nucleotides. J. Pharmacol. Exp. Ther. 242 (1987), 864–872.
82. Kawamoto, J.H., McLaughlin, B.E., Brien, J.F., Marks, G.S., Nakatsu, K., Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation. J. Cardiovasc. Pharmacol. 15 (1990), 714–719.
83. Kim, N., Azadzoi, K.M., Goldstein, I., de Tajeda, I.S., A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cav-ernosum smooth muscle. J. Clin. Invest. 88 (1991), 112–118.
84. Kimura, H., Mittal, C.K., Murad, F., Increases in cyclic GMP levels in brain and liver with sodium azide, an activator of guanylate cyclase. Nature (London) 257 (1975), 700–702.
85. Kimura, H., Mittal, C.K., Murad, F., Activation of guanylate cyclase from rat liver and other tissues with sodium azide. J. Biol. Chem. 250 (1975), 8016–8022.
86. Kisch, B., Electron microscopy of the atrium of the heart. I. Guinea pig. Exp. Med. Surg. 14 (1956), 99–112.
87. Kleinert, H.D., Maack, T., Atlas, S.A., Atrial natriuretic factor inhibits angiotensin-, norepinephrine- and potassium-induced vascular contractility. Hypertension 6:Suppl. I (1984), I-143–I-147.
88. Klinge, E., Sjöstrand, N.O., Contraction and relaxation of the retractor penis muscle and the penile artery of the bull. Acta Physiol. Scand., Suppl. 420 (1974), 1–88.
89. Kobayishi, A., Suzuki, Y., Kamikawa, T., Hayashi, H., Yamazaki, N., The effects of nitroglycerin on cyclic nucleotides in the coronary artery in vivo. Life Sci. 27 (1980), 1679–1685.
90. Koesling, D., Herz, J., Gausepohl, H., Niroomand, F., Hinsch, K.-D., Mülsch, A., Böhme, E., Schultz, G., Frank, R., The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase. FEBS Lett. 239 (1988), 29–34.
91. Kojima, M., Minamino, N., Kangawa, K., Matsuo, H., Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem. Biophys. Res. Commun. 159 (1989), 1420–1426.
92. Roller, K.J., Lowe, D.G., Bennet, G.L., Minamino, N., Kangawa, K., Matsuo, H., Goeddel, D.V., Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252 (1991), 120–123.
93. Andresen, T., Kuno, J., Komisaki, Y., Waldman, S.A., Chang, L., Soheki, S., Leitman, D., Nakone, M., Murad, F., Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclose from rat lung. J. Biol. Chem. 261 (1986), 5817–5823.
94. Li, C.G., Rand, M.J., Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol. 191 (1990), 303–309.
95. Lincoln, T.M., Effects of nitroprusside and 8-bromo cyclic GMP on the contractile activity of the rat aorta. J. Pharmacol. Exp. Ther. 224 (1983), 100–107.
96. Lincoln, T.M., Cyclic GMP and mechanisms of vasodilation. Pharmacol. Ther. 41 (1989), 479–502.
97. Lincoln, T.M., Cornwell, T.L., Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28 (1991), 129–137.
98. Lincoln, T.M., Hall, C.L., Park, C.R., Corbin, J.D., Guanosine 3′:5′-monophosphate binding proteins in rat tissues. Proc. Natl. Acad. Sci. U.S.A. 73 (1976), 2559–2563.
99. Lincoln, T.M., Dills, W.L., Corbin, J.D., Purification and subunit composition of guanosine 3′ :5′-monophosphate-dependent protein kinase from bovine lung. J. Biol. Chem. 252 (1977), 4269–4275.
100. Lincoln, T.M., Thompson, M., Cornwell, T.L., Purification and characterization of two forms of cyclic GMP-dependent protein kinase from bovine aorta. J. Biol. Chem. 263 (1988), 17632–17637.
101. Lindgren, S.H.S., Andersson, T.L.G., Vinge, E., Andersson, K.-E., Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: Smooth muscle tone, platelet aggregation and cAMP levels. Acta Physiol. Scand. 140 (1990), 209–219.
102. Lindgren, S., Rascón, A., Andersson, K.-E., Manganiello, V., Degerman, E., Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phospho-diesterases and relaxation of rat aorta. Biochem. Pharmacol. 42 (1991), 545–552.
103. Lorenz, K.L., Wells, J.N., Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors. Mol. Pharmacol. 23 (1983), 424–430.
104. Lowe, D.G., Chang, M.-S., Hellmiss, R., Chen, E., Singh, S., Garbers, D.L., Goeddel, D.V., Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J. 8 (1989), 1377–1384.
105. Martin, W., Villani, G.M., Jothianandan, D., Furchgott, R.F., Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by haemoglobin and methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232 (1985), 708–716.
106. Maurice, D.H., Haslam, R.J., Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle. Eur. J. Pharmacol. 191 (1990), 471–475.
107. Meisheri, K.D., Taylor, C.J., Saneii, H.H., Synthetic atrial peptide inhibits intracellular Ca++ release in smooth muscle. Am. J. Physiol. 250 (1986), C171–C174.
108. Mirzazdeh, S., Hobbs, A.J., Tucker, J.F., Gibson, A., Cyclic nucleotide content of the rat anococcygeus during relaxations induced by drugs or by non-adrenergic, non-cholinergic field stimulation. J. Pharm. Pharmacol. 43 (1991), 247–257.
109. Mitchell, J.A., Sheng, H., Förstermann, U., Murad, F., Characterization of nitric oxide synthases in non-adrenergic noncholinergic nerve containing tissue from the rat anococcygeus. Br. J. Pharmacol. 104 (1991), 289–291.
110. Miwa, K., Toda, N., The regional difference of relaxations induced by various vasodilators in isolated dog coronary and mesenterial arteries. Jpn. J. Pharmacol. 38 (1985), 313–330.
111. Mollace, V., Salvemini, D., Anggard, E., Vane, J., Nitric oxide from vascular smooth muscle cells: Regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br. J. Pharmacol. 104 (1991), 633–638.
112. Moritiko, H., Ueda, H., Yamamoto, T., Hisayama, T., Takeuchi, S., L-Arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation. Br. J. Pharmacol. 102 (1991), 841–846.
113. Murad, F., Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78 (1986), 1–5.
114. Murad, F., Mittal, C.K., Arnold, W.P., Katsuki, S., Kimura, H., Guanylate cyclase: Activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucleotide Res. 9 (1978), 145–158.
115. Murad, F., Mittal, C.K., Arnold, W.P., Braughler, J.M., Effect of nitro-compound smooth muscle relaxants and other materials on cyclic GMP metabolism. Adv. Pharmacol. Thera. 3 (1978), 123–132.
116. Nakane, M., Saheki, S., Kuno, T., Ishii, K., Murad, F., Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem. Biophys. Res. Commun. 157 (1988), 1139–1147.
117. Nakane, M., Arai, K., Saheki, S., Kuno, T., Buechler, W., Murad, F., Molecular cloning and expression of cDNAs coding soluble guanylate cyclase from rat lung. J. Biol. Chem. 265 (1990), 16841–16845.
118. Natanson, C., Eichenholz, P.W., Danner, R.L., Eichacker, P.Q., Hoffman, W.D., Kuo, G.C., Banks, S.M., MacVittie, T.J., Parrillo, J.E., Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169 (1989), 823–832.
119. Needleman, P.J., Blehm, D.J., Rotskoff, K.S., Relationship between glutathione-dependent denitration and the vasodilator effectiveness of organic nitrates. J. Pharmacol. Exp. Ther. 237 (1969), 286–288.
120. O'Donnell, M.E., Owen, N.E., Atrial natriuretic factor stimulates Na/K/Cl cotransport in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 6132–6136.
121. Ohlstein, E.H., Berkowitz, B.A., Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic factor. Hypertension 7 (1985), 306–310.
122. Otsuka, Y., DiPiero, A., Hirt, E., Brennaman, B., Lockette, W., Vascular relaxation and cyclic GMP in hypertension. Am. J. Physiol. 254 (1988), H163–H169.
123. Palmer, R.M.J., Ferridge, A.G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327 (1987), 524–526.
124. Palmer, R.M.J., Ashton, D.S., Moncada, S., Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (London) 333 (1988), 664–666.
125. Palmer, R.M.J., Rees, D.D., Ashton, D.S., Moncada, S., L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153 (1988), 1251–1256.
126. Pollock, J.S., Förstermann, U., Mitchell, J.A., Warner, T.D., Schmidt, H.H.H.W., Nakane, M., Murad, F., Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 10480–10484.
127. Popescu, L.M., Panoiu, C., Hinescu, M., Nutu, O., The mechanism of cGMP-induced relaxation in vascular smooth muscle. Eur. J. Pharmacol. 107 (1985), 393–394.
128. Radany, E.W., Gerzer, R., Garbers, D.L., Purification and characterization of particulate guanylate cyclase from sea urchin spermatozoa. J. Biol. Chem., 258, 1983, 8346.
129. Raeymaekers, L., Hofmann, F., Casteels, R., Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem. J. 252 (1988), 269–273.
130. Rapoport, R.M., Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ. Res. 58 (1986), 407–410.
131. Rapoport, R.M., Murad, F., Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ. Res. 52 (1983), 352–357.
132. Rapoport, R.M., Murad, F., Endothelium-dependent and nitrovasodilation induced relaxation of vascular smooth muscle: Role for cyclic GMP. J. Cyclic Nucleotide Protein Phosphorylation Res. 9 (1983), 281–296.
133. Rapoport, R.M., Draznin, M.B., Murad, F., Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature (London) 306 (1983), 174–176.
134. Rees, D.D., Palmer, R.M.J., Moncada, S., Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 3375–3378.
135. Resink, T., Scott-Burden, T., Baur, U., Jones, C.T., Buhler, F.R., Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth muscle cells. Eur. J. Biochem. 172 (1988), 499–505.
136. Romanin, C., Kukovetz, W.R., Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J. Mol. Cell. Cardiol. 21 (1989), 41–48.
137. Rosenzweig, A., Seidman, C.E., Atrial natriuretic factor and related peptide hormones. Annu. Rev. Biochem. 60 (1991), 229–255.
138. Saito, Y., Nakao, K., Itoh, H., Yamada, T., Mukoyama, M., Arai, H., Hosoda, K., Shirakami, G., Suga, S.-I., Minamino, N., Kangawa, K., Matsuo, H., Imura, H., Brain natriuretic peptide is a novel cardiac hormone. Biochem. Biophys. Res. Commun. 158 (1989), 360–368.
139. Sakuma, I., Stuehr, D.J., Gross, S.S., Nathan, C., Levi, R., Identification of L-arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A. 85 (1988), 8664–8667.
140. Schaller, M.D., Waeber, B., Nussberger, J., Brunner, H.R., Angiotensin II, vasopressin and sympathetic activity in conscious rats with endotoxaemia. Am. J. Physiol. 249 (1985), H1086–H1092.
141. Schini, V.B., Junquero, D.C., Scott-Burden, T., Vanhoutte, P.M., Interleukin-1β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem. Biophys. Res. Commun. 176 (1991), 114–121.
142. Schröder, H., Leitman, D.C., Bennet, B.M., Waldman, S.A., Murad, F., Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibro-blasts. J. Pharmacol. Exp. Ther. 245 (1988), 413–418.
143. Sheng, H., Ishii, K., Murad, F., Generation of endothelium-derived relaxing factor-like substance in bovine tracheal smooth muscle. Am. J. Physiol. 260 (1991), L489–L493.
144. Sheng, H., Schmidt, H., Nakane, M., Mitchell, J., Pollock, J., Forstermann, U., Murad, F., Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles. Br. J. Pharmacol. 106 (1992), 768–773.
145. Sheng, H., Mitchell, J.A., Nakane, M., Schmidt, H.H.H.W., Pollock, J.S., Warner, T.D., Förstermann, U., Murad, F., Characterization of NO synthase from non-adrenergic non-cholinergic nerves in rat anococcygeus and bovine retractor penis muscles. Moncada, S., Marietta, M.A., Hibbs, J.B. Jr., Higgs, E.A., (eds.) “Biology of Nitric Oxide”, II, 1993, Springer-Verlag, Berlin, 108–110.
146. Shibata, T., Ogawa, K., Ito, T., Hashimoto, H., Nakagawa, H., Satake, T., Role of cyclic GMP in canine vascular smooth muscle relaxation by organic nitroesters. Jpn. Circ. J. 50 (1986), 1091–1099.
147. Silver, P.J., Lepore, R.E., O'Connor, B., Lemp, B.M., Hamel, L.T., Bentley, R.G., Harris, A.L., Inhibition of the low Km cyclic AMP phosphodiesterase and activation of cyclic AMP system in vascular smooth muscle by milrinone. J. Pharmacol. Exp. Ther. 247 (1988), 34–42.
148. Sjöstrand, N.O., Eldh, J., Samuelson, U.E., Alaranta, S., Klinge, E., The effects of L-arginine and NG-monomethyl L-arginine on the inhibitory neurotransmission of the human corpus cavernosum. Acta Physiol. Scand. 140 (1990), 297–298.
149. Sudoh, T., Kangawa, K., Minamino, N., Matsuo, H., A new natriuretic peptide in porcine brain. Nature (London) 332 (1989), 78–81.
150. Sudoh, T., Minamino, N., Kangawa, K., Matsuo, H., C type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168 (1990), 863–870.
151. Taylor, C.J., Meisheri, K.D., Inhibitory effects of a synthetic atrial peptide on contractions and 45Ca fluxes in vascular smooth muscle. J. Pharmacol. Exp. Ther. 237 (1986), 803–808.
152. Tesafamariam, B., Weisbrod, R.M., Cohen, R.A., Endothelium inhibits responses of rabbit carotid artery to adrenergic nerve stimulation. Am. J. Physiol., 253, 1987, H792.
153. Thorpe, D.S., Garbers, D.L., The membrane form of guanylate cyclase: homol-ogy with a subunit of the cytoplasmic form of the enzyme. J. Biol. Chem. 264 (1989), 6545–6549.
154. Tillmanns, H., Steinhausen, M., Leinberger, H., Thederan, H., Different response of the ventricular micro-circulation to coronary vasodilators. Circulation, 60(Suppl. I), 1979, 142.
155. Toda, N., Baba, H., Okamura, T., Role of nitric oxide in nonadrenergic, non-cholinergic nerve mediated relaxation in dog duodenal longitudinal muscle strips. Jpn. J. Pharmacol. 53 (1990), 281–284.
156. Toda, N., Minami, Y., Okamura, T., Inhibitory effects of L-NG-nitro-arginine on the synthesis of EDRF and the cerebroarterial response to vasodilator nerve stimulation. Life Sci. 47 (1990), 345–351.
157. Torphy, T.J., Fine, C.F., Burman, M., Barnette, M.S., Ormsbee, H.S., Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content. Am. J. Physiol. 251 (1986), G786–G793.
158. Tøttrup, A., Svane, D., Forman, A., Nitric oxide mediating NANC inhibition in opossum lower esophogeal sphincter. Am. J. Physiol. 260 (1991), G385–G389.
159. Tucker, J.F., Brave, S.R., Charalambous, L., Hobbs, A., Gibson, A., L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br. J. Pharmacol. 100 (1990), 663–664.
160. Twort, C.H.C., van Breemen, C., Cyclic guanosine monophosphate-enhanced sequestration of Ca2+ by sarcoplasmic reticulum in smooth muscle. Circ. Res. 62 (1988), 961–964.
161. Vidal, M, Vanhoutte, P.M., Miller, V.M., Dissociation between endothelium-dependent relaxations and increases in cGMP in systemic veins. Am. J. Physiol. 260 (1991), H1531–H1537.
162. Vrolix, M., Raeymaekers, L., Wuytack, F., Hofmann, F., Casteels, R., Cyclic GMP-dependent protein kinase stimulates the plasmalemmal Ca2+ pump of smooth muscle via phosphorylation of phosphatidylinositol. Biochem. J 255 (1988), 855–863.
163. Wakabayishi, I., Hatake, K., Kakishita, E., Nagai, K., Diminuition of contractile response of the aorta from endotoxin-injected rats. Eur. J. Pharmacol. 141 (1987), 117–122.
164. Waldman, S.A., Murad, F., Cyclic GMP synthesis and function. Pharmacol. Rev. 39 (1987), 163–196.
165. Waldman, S.A., Rapoport, R., Ginsburg, R., Murad, F., Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem. Pharmacol. 35 (1986), 3525–3531.
166. Waldman, S.A., Rapoport, R., Murad, F., Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissue. J. Biol. Chem. 259 (1984), 14332–14334.
167. Wingren, A.-K., Axelsson, K.L., Andersson, R.G.G., Enzymatic denitration of organic nitro-esters as a possible requirement for causing cGMP elevation of vascular smooth muscle. Acta Pharmacol. Toxicol., 49(Suppl. III), 1981, 49.
168. Winquist, R.J., The relaxant effects of atrial natriuretic factor on vascular smooth muscle. Life Sci. 37 (1985), 1081–1087.
169. Winquist, R.J., Faison, E.P., Nutt, R.F., Vasodilator profile of synthetic atrial natriuretic factor. Eur. J. Pharmacol. 102 (1984), 169–173.
170. Winquist, R.J., Faison, E.P., Waldman, S.A., Schwartz, K., Murad, F., Rapoport, R.A., Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 81 (1984), 7661–7665.
171. Winquist, R.J., Napier, M.A., Vandlen, R.L., Arcuri, K., Keegan, M.E., Faison, E.P., Baskin, E.P., Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscle. Clin. Exp. Hypertens. A7 (1985), 869–884.
172. Wolfe, L., Corbin, J.D., Francis, S.H., Characterization of a novel isoenzyme of cGMP-dependent protein kinase from bovine aorta. J. Biol. Chem. 264 (1989), 7734–7741.
173. Wood, K.S., Buga, G.M., Byrns, R.E., Ignarro, L.J., Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem. Biophys. Res. Commun. 170 (1990), 80–88.
174. Word, R.A., Casey, M.L., Kamm, K.E., Stull, J.T., Effects of cGMP on [Ca2+]i, myosin light chain phosphorylation. and contraction in human myometrium. Am. J. Physiol. 260 (1991), C861–C867.
175. Yeates, R.A., Lauffen, H., Leithold, M., The reaction between organic nitrates and sulfhydryl compounds. A possible model system for the activation of organic nitrates. Mol. Pharmacol. 28 (1985), 555–559.
176. Zhou, H.-L., Torphy, T.J., Relationship between cyclic guanosine monophos-phate accumulation and relaxation of canine trachealis induced by nitrovasodilators. J. Pharmacol. Exp. Ther. 258 (1991), 972–978.
177. Zimmerman, A.L., Yamanaka, G., Eckstein, F., Baylor, D.A., Stryer, L., Interaction of hydrolysis-resistant analogs of cyclic GMP with the phosphodiesterase and light-sensitive channel of retinal rod outer segments. Proc. Natl. Acad. Sci. U.S.A. 82 (1985), 8813–8817.